The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Salgia, Ravi
Item TypeName
Concept Drug Resistance
Concept Drug Resistance, Neoplasm
Concept Drug Resistance, Multiple
Academic Article 2-methoxyestradiol alters cell motility, migration, and adhesion.
Academic Article Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
Academic Article Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
Academic Article EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
Academic Article Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Academic Article Personalized treatment of lung cancer.
Academic Article Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
Academic Article Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.
Academic Article MET as a possible target for non-small-cell lung cancer.
Academic Article Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.
Academic Article AXL mediates resistance to cetuximab therapy.
Academic Article Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Academic Article Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Academic Article AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Academic Article Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Academic Article Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Academic Article Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Academic Article RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Academic Article MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.
Academic Article Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
Academic Article Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Academic Article The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.
Academic Article Managing Patients With Relapsed Small-Cell Lung Cancer.
Academic Article The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer.
Academic Article RLIP: An existential requirement for breast carcinogenesis.
Academic Article USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks.
Academic Article SOX9: The master regulator of cell fate in breast cancer.
Academic Article AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer.
Academic Article Activating p53 function by targeting RLIP.
Academic Article Group Behavior and Emergence of Cancer Drug Resistance.
Academic Article Quantifying Cancer: More Than Just a Numbers Game.
Academic Article Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
Academic Article Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy.
Academic Article AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
Academic Article Addressing Drug Resistance in Cancer: A Team Medicine Approach.
Academic Article Precision oncology provides opportunities for targeting KRAS-inhibitor resistance.
Academic Article Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.
Academic Article Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
Academic Article A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.
Search Criteria
  • Drug resistance